We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Redx Pharma Plc | LSE:REDX | London | Ordinary Share | GB00BSNB6S51 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.50 | 22.73% | 13.50 | 13.00 | 14.00 | 13.75 | 11.00 | 11.25 | 1,069,536 | 16:25:57 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 4.2M | -33.16M | -0.0852 | -1.58 | 52.51M |
TIDMREDX TIDMAV.
RNS Number : 4280K
Redx Pharma plc
21 September 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) ------------------------------------------------------------------------ 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: (ii) --------------------------------------------------------------------------------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------- ------------------------------------------ An acquisition or disposal Redx Pharma Plc of voting rights ------------------------------------------------------------------- ------------------------------------------ An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached --------------------------------------------------------------------------------------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ---------------------------------------------------------------------- --------------------------------------- An event changing the breakdown of voting rights ---------------------------------------------------------------------- --------------------------------------- Other (please specify): ---------------------------------------------------------------------- --------------------------------------- 3. Full name of person(s) subject to the notification obligation: (iii) ---------------------------------------------------------------------- --------------------------------------- 4. Full name of shareholder(s) (if different from 3.):(iv) --------------------------------------------------------------- ----- --------------------------------------- 5. Date of the transaction Aviva plc & its subsidiaries and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------------- -------------------------------------------- 6. Date on which issuer Registered Holder: notified: BNY Norwich Union Nominees Limited 321,098* Chase (GA Group) Nominees Limited 4,685,774* State Street Nominees Limited 1,216,783* *denotes direct interest Chase (GA Group) Nominees Limited 319,659 Chase Nominees Limited 178,590 ----------------------------------------------------------------- -------------------------------------------- 7. Threshold(s) that is/are 19 September 2016 crossed or reached: (vi, vii) ----------------------------------------------------------------- -------------------------------------------- 8. Notified details: -------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) -------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------------- ------------------------------ --------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ------------------- ------------------ ---------- ------------ ---------------------- ------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------------- ------------------ ---------- ------------ ---------- ---------- ------- ---------- Ordinary Shares GB00BSNB6S51 7,754,352 7,754,352 6,721,904 6,223,655 498,249 6.65% 0.54% ------------------ ---------- ------------ ---------- ---------- ------- ---------- B: Qualifying Financial Instruments -------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction -------------------------------------------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of voting % of voting instrument date Conversion rights that rights (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ------------------- ------------------ ------------------------ ---------------------- ------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ----------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------- Type of financial Exercise Expiration Exercise/ Number of voting % of voting instrument price date Conversion rights instrument rights (xix, (xvii) period refers to xx) (xviii) ------------------ --------- ----------- ------------ ------------------- ---------------- Nominal Delta ------------------ --------- ----------- ------------ ------------------- -------- ------ Total (A+B+C) ------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------ ---------------------------- 6,721,904 7.19% ------------------------ ---------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) --------------------------------------------------------------- The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:- Aviva Investors Global Services Limited: * Aviva plc (Parent Company) * Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) * Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) * Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited) Proxy Voting: --------------------------------------------------------------- 10. Name of the proxy holder: See Section 4 -------------------------------------------- ----------------- 11. Number of voting rights proxy holder will cease to hold: -------------------------------------------- ----------------- 12. Date on which proxy holder will cease to hold voting rights: -------------------------------------------- ----------------- 13. Additional information: Figures are based on a total number of voting rights of 93,552,638 as per the Company's 'Result of General Meeting and Issue of Equity' Announcement of 13 April 2016. ------------------------------- ------------------------------------ 14. Contact name: Neil Whittaker, Aviva plc ------------------------------- ------------------------------------ 15. Contact telephone number: 01603 684420 ------------------------------- ------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGRGDCRSDBGLB
(END) Dow Jones Newswires
September 21, 2016 03:51 ET (07:51 GMT)
1 Year Redx Pharma Chart |
1 Month Redx Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions